| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| b' Jeremy Carlier, Marilyn A Huestis, Simona Zaami, Simona Pichini, Francesco P Busard\\xc3\\xb. Monitoring Perinatal Exposure to Cannabis and Synthetic Cannabinoids. Therapeutic drug monitoring. vol 42. issue 2. 2021-05-05. PMID:32195988.' |
obstetric complications with increased risks of miscarriage, fetal growth restriction, and brain development impairment have been associated with perinatal cannabis exposure, but data on synthetic cannabinoid use during pregnancy are limited. |
2021-05-05 |
2023-08-13 |
Not clear |
| Sharon R Sznitman, Lianna Pinsky-Talbi, Maisar Salameh, Taleb Moed, Yedidia Bentu. Cannabis and synthetic cannabinoid exposure reported to the Israel poison information center: Examining differences in exposures to medical and recreational compounds. The International journal on drug policy. vol 77. 2021-05-04. PMID:32126489. |
cannabis and synthetic cannabinoid exposure reported to the israel poison information center: examining differences in exposures to medical and recreational compounds. |
2021-05-04 |
2023-08-13 |
Not clear |
| Sharon R Sznitman, Lianna Pinsky-Talbi, Maisar Salameh, Taleb Moed, Yedidia Bentu. Cannabis and synthetic cannabinoid exposure reported to the Israel poison information center: Examining differences in exposures to medical and recreational compounds. The International journal on drug policy. vol 77. 2021-05-04. PMID:32126489. |
synthetic cannabinoids, often marketed as cannabis replacement, have recently emerged and knowledge and awareness of their toxic effects is growing. |
2021-05-04 |
2023-08-13 |
Not clear |
| Sharon R Sznitman, Lianna Pinsky-Talbi, Maisar Salameh, Taleb Moed, Yedidia Bentu. Cannabis and synthetic cannabinoid exposure reported to the Israel poison information center: Examining differences in exposures to medical and recreational compounds. The International journal on drug policy. vol 77. 2021-05-04. PMID:32126489. |
the objective of this study was to characterize and compare cannabinoid poisonings (medical and recreational cannabis, and synthetic cannabinoids) in israel during the period 2007-2018. |
2021-05-04 |
2023-08-13 |
Not clear |
| David Fabregat-Safont, María Ibáñez, Abel Baquero, Juan Vicente Sancho, Félix Hernández, Gonzalo Har. Investigation on the consumption of synthetic cannabinoids among teenagers by the analysis of herbal blends and urine samples. Journal of pharmaceutical and biomedical analysis. vol 186. 2021-05-04. PMID:32325401. |
the use of synthetic cannabinoids (scs), which escape conventional detection systems, may be a good alternative to elude routine drug analysis for cannabis. |
2021-05-04 |
2023-08-13 |
Not clear |
| Marco Ternelli, Virginia Brighenti, Lisa Anceschi, Massimiliano Poto, Davide Bertelli, Manuela Licata, Federica Pellat. Innovative methods for the preparation of medical Cannabis oils with a high content of both cannabinoids and terpenes. Journal of pharmaceutical and biomedical analysis. vol 186. 2021-05-04. PMID:32334134. |
innovative methods for the preparation of medical cannabis oils with a high content of both cannabinoids and terpenes. |
2021-05-04 |
2023-08-13 |
Not clear |
| Kenna Lewis, Rebecca Wagner, Sandra E Rodriguez-Cruz, Michael J Weaver, Jonathan C Dumk. Validation of the 4-aminophenol color test for the differentiation of marijuana-type and hemp-type cannabis. Journal of forensic sciences. vol 66. issue 1. 2021-05-04. PMID:32956496. |
validation studies included the testing of numerous cannabinoid reference materials, household herbs, previously characterized cannabis plant samples, and real-case samples. |
2021-05-04 |
2023-08-13 |
Not clear |
| b' Al\\xc5\\xbeb\\xc4\\x9bta Neme\\xc5\\xa1kalov\\xc3\\xa1, Kate\\xc5\\x99ina H\\xc3\\xa1jkov\\xc3\\xa1, Luk\\xc3\\xa1\\xc5\\xa1 Mikul\\xc5\\xaf, David S\\xc3\\xbdkora, Martin Kucha\\xc5\\x9. Combination of UV and MS/MS detection for the LC analysis of cannabidiol-rich products. Talanta. vol 219. 2021-04-30. PMID:32887141.' |
cannabidiol (cbd), a major non-psychoactive cannabinoid, has received a lot of attention due to its potential anti-inflammatory, pain-relieving, and anti-anxiety properties. |
2021-04-30 |
2023-08-13 |
Not clear |
| Rahul Nachnani, Wesley M Raup-Konsavage, Kent E Vran. The Pharmacological Case for Cannabigerol. The Journal of pharmacology and experimental therapeutics. vol 376. issue 2. 2021-04-30. PMID:33168643. |
medical cannabis and individual cannabinoids, such as Δ9-tetrahydrocannabinol (Δ9-thc) and cannabidiol (cbd), are receiving growing attention in both the media and the scientific literature. |
2021-04-30 |
2023-08-13 |
Not clear |
| Recardia Schoeman, Natasha Beukes, Carminita Fros. Cannabinoid Combination Induces Cytoplasmic Vacuolation in MCF-7 Breast Cancer Cells. Molecules (Basel, Switzerland). vol 25. issue 20. 2021-04-29. PMID:33066359. |
the most promising cannabinoid combination (c6) consisted of tetrahydrocannabinol, cannabigerol (cbg), cannabinol (cbn), and cannabidiol (cbd), and displayed favorable dose reduction indices and limited cytotoxicity against the non-cancerous breast cell line, mcf-10a. |
2021-04-29 |
2023-08-13 |
human |
| Catherine F Moore, Jeffrey W Stiltner, Catherine M Davis, Elise M Weert. Translational models of cannabinoid vapor exposure in laboratory animals. Behavioural pharmacology. 2021-04-29. PMID:33136615. |
the most common route of administration for cannabis and cannabinoid constituents such as Δ-9-tetrahydrocannabinol (thc) and cannabidiol (cbd) is via smoking or vapor inhalation. |
2021-04-29 |
2023-08-13 |
Not clear |
| Sharda Kotru, Martin Klimuntowski, Hashim Ridha, Zakir Uddin, Ali A Askhar, Gurmit Singh, Matiar M R Howlade. Electrochemical sensing: A prognostic tool in the fight against COVID-19. Trends in analytical chemistry : TRAC. vol 136. 2021-04-29. PMID:33518850. |
cannabinoids, especially cannabidiol (cbd), are discussed as a potential adjunct therapy for covid-19 as their medicinal properties may be desirable in minimizing the neurodegenerative or severe inflammatory damage caused by severe covid-19 infection. |
2021-04-29 |
2023-08-13 |
Not clear |
| Yuanyuan Liu, Panpan Zhu, Sen Cai, George Haughn, Jonathan E Pag. Three novel transcription factors involved in cannabinoid biosynthesis in Cannabis sativa L. Plant molecular biology. vol 106. issue 1-2. 2021-04-29. PMID:33625643. |
three novel transcription factors involved in cannabinoid biosynthesis in cannabis sativa l. three novel transcription factors were successfully identified and shown to interact with the trichome-specific thcas promoter regulatory region. |
2021-04-29 |
2023-08-13 |
Not clear |
| Yuanyuan Liu, Panpan Zhu, Sen Cai, George Haughn, Jonathan E Pag. Three novel transcription factors involved in cannabinoid biosynthesis in Cannabis sativa L. Plant molecular biology. vol 106. issue 1-2. 2021-04-29. PMID:33625643. |
cannabinoids are important secondary metabolites present in cannabis sativa l. (cannabis). |
2021-04-29 |
2023-08-13 |
Not clear |
| Yuanyuan Liu, Panpan Zhu, Sen Cai, George Haughn, Jonathan E Pag. Three novel transcription factors involved in cannabinoid biosynthesis in Cannabis sativa L. Plant molecular biology. vol 106. issue 1-2. 2021-04-29. PMID:33625643. |
one cannabinoid that has received considerable attention, 9-tetrahydrocannabinol (thc), is derived from delta-9-tetrahydrocannabinolic acid (thca) and responsible for the mood-altering and pain-relieving effects of cannabis. |
2021-04-29 |
2023-08-13 |
Not clear |
| Jodi M Gilman, William A Schmitt, Grace Wheeler, Randi M Schuster, Jost Klawitter, Cristina Sempio, A Eden Evin. Variation in Cannabinoid Metabolites Present in the Urine of Adults Using Medical Cannabis Products in Massachusetts. JAMA network open. vol 4. issue 4. 2021-04-29. PMID:33844003. |
variation in cannabinoid metabolites present in the urine of adults using medical cannabis products in massachusetts. |
2021-04-29 |
2023-08-13 |
Not clear |
| Judy Trac, J Myles Keck, Joseph E Dewees. Cannabidiol oxidation product HU-331 is a potential anticancer cannabinoid-quinone: a narrative review. Journal of cannabis research. vol 3. issue 1. 2021-04-28. PMID:33892826. |
cannabidiol and related cannabinoids are under exploration for the treatment of a number of disease states. |
2021-04-28 |
2023-08-13 |
human |
| Paolo Taurisano, Giulio Pergola, Anna Monda, Linda A Antonucci, Pasquale Di Carlo, Francesco Piarulli, Roberta Passiatore, Marco Papalino, Raffaella Romano, Alfonso Monaco, Antonio Rampino, Aurora Bonvino, Annamaria Porcelli, Teresa Popolizio, Roberto Bellotti, Alessandro Bertolino, Giuseppe Blas. The interaction between cannabis use and a CB1-related polygenic co-expression index modulates dorsolateral prefrontal activity during working memory processing. Brain imaging and behavior. vol 15. issue 1. 2021-04-27. PMID:32124274. |
convergent findings indicate that cannabis use and variation in the cannabinoid cb1 receptor coding gene (cnr1) modulate prefrontal function during working memory (wm). |
2021-04-27 |
2023-08-13 |
human |
| Alistair W Vickery, Phillip M Finc. Cannabis: are there any benefits? Internal medicine journal. vol 50. issue 11. 2021-04-27. PMID:33215831. |
herbal cannabis with Δ9-tetrahydrocannabinol (thc), which is illegal, and cannabidiol (cbd) in herbal extracts, are both unregulated and unreliable sources of cannabinoids. |
2021-04-27 |
2023-08-13 |
Not clear |
| Ewa Galaj, Guo-Hua Bi, Hong-Ju Yang, Zheng-Xiong X. Cannabidiol attenuates the rewarding effects of cocaine in rats by CB2, 5-HT Neuropharmacology. vol 167. 2021-04-23. PMID:31437433. |
cannabidiol (cbd) is a u.s. fda-approved cannabinoid for the treatment of epilepsy and recently was reported to have therapeutic potential for other disorders. |
2021-04-23 |
2023-08-13 |
rat |